monoclonal

Documents about monoclonal

• Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.#1058896ClinicalTrials.gov
• Unravel MGUS (Monoclonal Gammopathy of Unknown Significance)#1375368ClinicalTrials.gov
• Frequency and Characteristics of Pruritus in Patients With Monoclonal Gammopathy#897259ClinicalTrials.gov
• Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat#1336814ClinicalTrials.gov
• Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody#1032464ClinicalTrials.gov
• Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis#813014ClinicalTrials.gov
• Monoclonal Antibodies in Pediatric Atopic Dermatitis; Efficacy and Safety#478485Europe PMC
• Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat Influenza#1228128ClinicalTrials.gov
• Monoclonal Antibodies in Clostridium Difficile Infection#1475940ClinicalTrials.gov
• Subarachnoid neurocysticercosis in a rural area of the Bolivian Chaco: A population-based survey through the use of a novel urine antigen assay#136441PLOS
• Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy#859660ClinicalTrials.gov
• Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults#1198446ClinicalTrials.gov
• Famílias Clonais em Eucalyptus#1017208RI UFLA
• Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection#1033437ClinicalTrials.gov
• A new pitfall in potassium testing: A case series of false elevation of hemolysis index in the presence of monoclonal protein#670012HAL (France)
• EXCIPIENTS FOR ENHANCING MONOCLONAL ANTIBODY STABILITY IN ORAL SOLID DOSAGE FORMS#288533ScholarBank@NUS
• The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma#848198ClinicalTrials.gov
• Neoadjuvant Chemoradiotherapy Combined With CTLA-4 Monoclonal Antibody Plus PD-1 Monoclonal Antibody for Locally Advanced Esophageal Cancer#1058534ClinicalTrials.gov
• Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults#993268ClinicalTrials.gov
• Oxford Pre-cancerous Lymphoproliferative Disorders Study#804563ClinicalTrials.gov
• Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL)#1371550ClinicalTrials.gov
• PD-1 Monoclonal Antibody in Pre-treated Lymphoepithelioma-like Carcinoma#1408953ClinicalTrials.gov
• A Study of Anti-HIV Monoclonal Antibody KD-247#895209ClinicalTrials.gov
• A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198#1280178ClinicalTrials.gov
• Efficacy of Montelukast in Reducing the Incidence and Severity of Monoclonal Antibodies Associated Infusion Reactions#1421120ClinicalTrials.gov
• A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH#1138503ClinicalTrials.gov
• Monoclonal Antibodies Accessing the Cytosol of Living Cells and Binding to Polo‐Like Kinase 1 Interdomain Linker Affect Mitotic Behavior#176828HAL (France)
• The Market for Monoclonal Antibodies: Trends, Challenges, and Opportunities.#240441PubMed
• Optimization strategies for monoclonal antibody production: advances in simulation and artificial intelligence in bioprocessing.#404592PubMed
• Monoclonal Antibody for Treatment of Inhalation Anthrax#1197409ClinicalTrials.gov
• Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study#185586IRIS
• Therapeutic approaches against dengue virus: current status of vaccines, antivirals, and monoclonal antibodies.#309484PubMed
• A Study of Carbon 13-based Deep Labelling of Bone Marrow Cells#1321806ClinicalTrials.gov
• Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis#1378236ClinicalTrials.gov
• Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD#1407810ClinicalTrials.gov
• Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma#1462699ClinicalTrials.gov
• Monoclonal antibodies against nitrated nerve growth factor reveal an oxidation-dependent pathogenic hallmark in ALS#301207HAL (France)
• A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors#885682ClinicalTrials.gov
• Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C#908027ClinicalTrials.gov
• Optimization strategies for monoclonal antibody production: advances in simulation and artificial intelligence in bioprocessing#651931Europe PMC
• Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal Antibodies#851367ClinicalTrials.gov
• Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2#907959ClinicalTrials.gov
• Study on Biomarkers to Predict the Efficacy of IL-4R Monoclonal Antibody for Chronic Rhino-sinusitis With Polyps#1321520ClinicalTrials.gov
• Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance#1398323ClinicalTrials.gov
• FC-OPTIMIZATION OF DNA-ENCODED MONOCLONAL ANTIBODIES: AN ALTERNATIVE APPROACH TO COMBATING ANTIMICROBIAL RESISTANCE#637519ScholarlyCommons at Penn
• Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics#651923Europe PMC
• Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment of Immunocompromised Patients#893033ClinicalTrials.gov
• Immune System Effects in Children Born to Women With Multiple Sclerosis Treated With Monoclonal Antibody Therapy During Pregnancy#1124770ClinicalTrials.gov
• Application of Orelabrutinib With or Without CD20 Monoclonal Antibody in Previously Untreated Marginal Zone Lymphoma#1162368ClinicalTrials.gov
• BIOmarkers of MIGraine: a Proof of Concept Study Based on the Stratification of Responders to CGRP Monoclonal Antibodies#1372579ClinicalTrials.gov